Show simple item record

The impact of JAK/STAT inhibitor ruxolitinib on the genesis of lymphoproliferative diseases

dc.contributor.authorTurk, Can
dc.contributor.authorOkay, Mufide
dc.contributor.authorTurk, Seyhan
dc.contributor.authorTemirci, Elif Sena
dc.contributor.authorJavad, Osama
dc.contributor.authorAksu, Sal
dc.contributor.authorSayinalp, Nilgun
dc.contributor.authorHaznedaroglu, Ibrahim Celalettin
dc.date.accessioned2020-10-26T12:24:22Z
dc.date.available2020-10-26T12:24:22Z
dc.date.issued2019
dc.identifier10.3906/sag-1807-152
dc.identifier.issn1300-0144
dc.identifier.urihttp://hdl.handle.net/20.500.12591/309
dc.sourceTurkish Journal of Medical Sciences
dc.titleThe impact of JAK/STAT inhibitor ruxolitinib on the genesis of lymphoproliferative diseases


Files in this item

Thumbnail
Name:
The impact of JAK STAT inhibitor ...
Size:
2.927Mb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record